BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 3362947)

  • 1. Haloperidol, but not apomorphine, differentially affects low response rates of male and female Wistar rats.
    Van Hest A; van Haaren F; van de Poll NE
    Pharmacol Biochem Behav; 1988 Mar; 29(3):529-32. PubMed ID: 3362947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered catecholaminergic behavioral and hormonal responses in rats following early postnatal hypoxia.
    Hermans RH; Longo LD
    Physiol Behav; 1994 Mar; 55(3):469-75. PubMed ID: 8190763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined.
    Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):153-64. PubMed ID: 6137027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
    de Bruin NM; van Luijtelaar EL; Cools AR; Ellenbroek BA
    Behav Pharmacol; 2001 Nov; 12(6-7):517-25. PubMed ID: 11742146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat.
    Castellani S; Adams PM
    Neuropharmacology; 1981 Apr; 20(4):371-4. PubMed ID: 7197334
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
    Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
    Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical changes induced by aging in dopaminergic systems of male and female rats.
    Dorce VA; Palermo-Neto J
    Physiol Behav; 1994 Nov; 56(5):1015-9. PubMed ID: 7824565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation.
    Amabeoku GJ
    Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P; Friedman E
    Eur J Pharmacol; 1988 Mar; 148(2):269-72. PubMed ID: 2897925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dihydroergotoxine on some dopamine-related behaviors in rats.
    Flório JC; Palermo-Neto J
    Gen Pharmacol; 1990; 21(4):411-5. PubMed ID: 2379797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.